InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
2.280
-0.065 (-2.77%)
At close: May 12, 2025, 4:00 PM
2.280
0.00 (0.00%)
After-hours: May 12, 2025, 4:00 PM EDT
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $2.75 million as of May 12, 2025. Its market cap has increased by 52.91% in one year.
Market Cap
2.75M
Enterprise Value
241.13K
1-Year Change
52.91%
Ranking
Category
Stock Price
$2.28
Market Cap Chart
Since November 16, 2020, InMed Pharmaceuticals's market cap has decreased from $26.00M to $2.75M, a decrease of -89.41%. That is a compound annual growth rate of -39.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 2.80M | -17.65% |
| Dec 31, 2024 | 3.40M | 54.55% |
| Dec 29, 2023 | 2.20M | 15.79% |
| Dec 30, 2022 | 1.90M | -89.73% |
| Dec 31, 2021 | 18.50M | -19.57% |
| Dec 31, 2020 | 23.00M | -11.54% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |